Integrated Diagnostics Holdings PLC
LSE:IDHC

Watchlist Manager
Integrated Diagnostics Holdings PLC Logo
Integrated Diagnostics Holdings PLC
LSE:IDHC
Watchlist
Price: 0.43 USD 1.3% Market Closed
Market Cap: 250m USD
Have any thoughts about
Integrated Diagnostics Holdings PLC?
Write Note

Intrinsic Value

The intrinsic value of one IDHC stock under the Base Case scenario is 0.56 USD. Compared to the current market price of 0.43 USD, Integrated Diagnostics Holdings PLC is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IDHC Intrinsic Value
0.56 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Integrated Diagnostics Holdings PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IDHC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IDHC?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Integrated Diagnostics Holdings PLC

Provide an overview of the primary business activities
of Integrated Diagnostics Holdings PLC.

What unique competitive advantages
does Integrated Diagnostics Holdings PLC hold over its rivals?

What risks and challenges
does Integrated Diagnostics Holdings PLC face in the near future?

Summarize the latest earnings call
of Integrated Diagnostics Holdings PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Integrated Diagnostics Holdings PLC.

Provide P/S
for Integrated Diagnostics Holdings PLC.

Provide P/E
for Integrated Diagnostics Holdings PLC.

Provide P/OCF
for Integrated Diagnostics Holdings PLC.

Provide P/FCFE
for Integrated Diagnostics Holdings PLC.

Provide P/B
for Integrated Diagnostics Holdings PLC.

Provide EV/S
for Integrated Diagnostics Holdings PLC.

Provide EV/GP
for Integrated Diagnostics Holdings PLC.

Provide EV/EBITDA
for Integrated Diagnostics Holdings PLC.

Provide EV/EBIT
for Integrated Diagnostics Holdings PLC.

Provide EV/OCF
for Integrated Diagnostics Holdings PLC.

Provide EV/FCFF
for Integrated Diagnostics Holdings PLC.

Provide EV/IC
for Integrated Diagnostics Holdings PLC.

Show me price targets
for Integrated Diagnostics Holdings PLC made by professional analysts.

What are the Revenue projections
for Integrated Diagnostics Holdings PLC?

How accurate were the past Revenue estimates
for Integrated Diagnostics Holdings PLC?

What are the Net Income projections
for Integrated Diagnostics Holdings PLC?

How accurate were the past Net Income estimates
for Integrated Diagnostics Holdings PLC?

What are the EPS projections
for Integrated Diagnostics Holdings PLC?

How accurate were the past EPS estimates
for Integrated Diagnostics Holdings PLC?

What are the EBIT projections
for Integrated Diagnostics Holdings PLC?

How accurate were the past EBIT estimates
for Integrated Diagnostics Holdings PLC?

Compare the revenue forecasts
for Integrated Diagnostics Holdings PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Integrated Diagnostics Holdings PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Integrated Diagnostics Holdings PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Integrated Diagnostics Holdings PLC compared to its peers.

Compare the P/E ratios
of Integrated Diagnostics Holdings PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Integrated Diagnostics Holdings PLC with its peers.

Analyze the financial leverage
of Integrated Diagnostics Holdings PLC compared to its main competitors.

Show all profitability ratios
for Integrated Diagnostics Holdings PLC.

Provide ROE
for Integrated Diagnostics Holdings PLC.

Provide ROA
for Integrated Diagnostics Holdings PLC.

Provide ROIC
for Integrated Diagnostics Holdings PLC.

Provide ROCE
for Integrated Diagnostics Holdings PLC.

Provide Gross Margin
for Integrated Diagnostics Holdings PLC.

Provide Operating Margin
for Integrated Diagnostics Holdings PLC.

Provide Net Margin
for Integrated Diagnostics Holdings PLC.

Provide FCF Margin
for Integrated Diagnostics Holdings PLC.

Show all solvency ratios
for Integrated Diagnostics Holdings PLC.

Provide D/E Ratio
for Integrated Diagnostics Holdings PLC.

Provide D/A Ratio
for Integrated Diagnostics Holdings PLC.

Provide Interest Coverage Ratio
for Integrated Diagnostics Holdings PLC.

Provide Altman Z-Score Ratio
for Integrated Diagnostics Holdings PLC.

Provide Quick Ratio
for Integrated Diagnostics Holdings PLC.

Provide Current Ratio
for Integrated Diagnostics Holdings PLC.

Provide Cash Ratio
for Integrated Diagnostics Holdings PLC.

What is the historical Revenue growth
over the last 5 years for Integrated Diagnostics Holdings PLC?

What is the historical Net Income growth
over the last 5 years for Integrated Diagnostics Holdings PLC?

What is the current Free Cash Flow
of Integrated Diagnostics Holdings PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Integrated Diagnostics Holdings PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Integrated Diagnostics Holdings PLC

Current Assets 2.7B
Cash & Short-Term Investments 1.3B
Receivables 886.1m
Other Current Assets 536.4m
Non-Current Assets 4.1B
PP&E 2.3B
Intangibles 1.8B
Current Liabilities 1.7B
Accounts Payable 283.5m
Accrued Liabilities 281m
Other Current Liabilities 1.1B
Non-Current Liabilities 2.3B
Long-Term Debt 1B
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
Integrated Diagnostics Holdings PLC

Revenue
4.7B EGP
Cost of Revenue
-3B EGP
Gross Profit
1.8B EGP
Operating Expenses
-883.9m EGP
Operating Income
907.4m EGP
Other Expenses
-90.1m EGP
Net Income
817.3m EGP

Free Cash Flow Analysis
Integrated Diagnostics Holdings PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the first quarter of 2024, IDH reported a 28% year-on-year top-line growth, reaching nearly EGP 1.2 billion. This growth was driven by an 18% increase in average revenue per test and an 8% rise in test volumes. Egypt remained the key market, contributing 85% of consolidated revenues. Despite geopolitical challenges in Nigeria and Jordan and the suspension of operations in Sudan, IDH's profitability improved, with a notable 139% rise in net profit. The company anticipates around 30% consolidated revenue growth and an EBITDA margin of 30% for the full year 2024.

What is Earnings Call?
Fundamental Scores

IDHC Profitability Score
Profitability Due Diligence

Integrated Diagnostics Holdings PLC's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROIC
66/100
Profitability
Score

Integrated Diagnostics Holdings PLC's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

IDHC Solvency Score
Solvency Due Diligence

Integrated Diagnostics Holdings PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
47/100
Solvency
Score

Integrated Diagnostics Holdings PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC

Wall Street analysts forecast IDHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDHC is 0.54 USD with a low forecast of 0.45 USD and a high forecast of 0.71 USD.

Lowest
Price Target
0.45 USD
6% Upside
Average
Price Target
0.54 USD
27% Upside
Highest
Price Target
0.71 USD
66% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IDHC?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IDHC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Integrated Diagnostics Holdings PLC Logo
Integrated Diagnostics Holdings PLC

Country

Jersey

Industry

Health Care

Market Cap

258m USD

Dividend Yield

0%

Description

Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).

Contact

Saint Helier
12 Castle Street
+441534847000.0
www.idhcorp.com

IPO

2015-05-06

Employees

4 754

Officers

Group CEO & Executive Director
Dr. Hend El Sherbini
Group CFO & Executive Director
Mr. Sherif Mohamed Mohamed El Zeiny
Chief Operating Officer
Dr. Eissa Khorshid
Director of Investor Relations
Tarek Yehia
General Counsel
Mr. Mohamed Kamel Saleh
Sales Director
Dr. Seham Ibrahim

See Also

Discover More
What is the Intrinsic Value of one IDHC stock?

The intrinsic value of one IDHC stock under the Base Case scenario is 0.56 USD.

Is IDHC stock undervalued or overvalued?

Compared to the current market price of 0.43 USD, Integrated Diagnostics Holdings PLC is Undervalued by 24%.

Back to Top